<?xml version="1.0" encoding="UTF-8"?>
<p>The avian influenza A (H7N9) virus infections in humans since 2013 in mainland China are unprecedented both in terms of mortality and morbidity, and the extent to which the disease spread has enlarged in the wave of 2016–17 [
 <xref rid="pone.0215857.ref001" ref-type="bibr">1</xref>–
 <xref rid="pone.0215857.ref003" ref-type="bibr">3</xref>]. Previous closely monitoring of virological and molecular characteristics of A (H7N9) virus in poultry and human beings emphasizes that A (H7N9) continues to emerge and spread into populations at risk [
 <xref rid="pone.0215857.ref004" ref-type="bibr">4</xref>–
 <xref rid="pone.0215857.ref009" ref-type="bibr">9</xref>]. Therefore, the risk assessment of A (H7N9) in humans is crucial for the preparedness and response of sporadic infections, epidemic, and even potential pandemic.
</p>
